Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
American Journal of Perinatology|January 3, 2018
Impact of Obesity on the Rate of Recurrent Spontaneous Preterm Birth in Women Treated with 17-alpha Hydroxyprogesterone CaproateAlisse Hauspurg, Lara S Lemon, Allison E Serra, et al.British Journal of Clinical Pharmacology|May 3, 2016
Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestationShringi Sharma, Steve Caritis, Gary Hankins, et al.Journal of Pharmaceutical and Biomedical Analysis|October 25, 2008
Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS)Shimin Zhang, Sripal Reddy Mada, Shringi Sharma, et al.Modern Rheumatology|December 30, 2011
A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitisShigeto Kobayashi, Masayoshi Harigai, Neelufar Mozaffarian, et al.British Journal of Clinical Pharmacology|July 15, 2021
Improved characterization of the pharmacokinetics of acalabrutinib and its pharmacologically active metabolite, ACP-5862, in patients with B-cell malignancies and in healthy subjects using a population pharmacokinetic approachHelena Edlund, Francesco Bellanti, Huan Liu, et al.The Pediatric Infectious Disease Journal|May 17, 2014
Palivizumab use in Japanese infants and children with immunocompromised conditionsMasaaki Mori, Masafumi Onodera, Akira Morimoto, et al.Clinical Drug Investigation|October 28, 2016
Pharmacokinetics, Pharmacodynamics, and Safety of Entospletinib, a Novel pSYK Inhibitor, Following Single and Multiple Oral Dosing in Healthy VolunteersSrini Ramanathan, Julie A Di Paolo, Feng Jin, et al.Pulmonary Pharmacology & Therapeutics|March 26, 2013
Three monthly doses of palivizumab are not adequate for 5-month protection: a population pharmacokinetic analysisWilliam V La Via, Gerard F Notario, Xiang-Qing Yu, et al.Clinical Pharmacology in Drug Development|February 16, 2019
The Relative Bioavailability and Effects of Food and Acid-Reducing Agents on Filgotinib Tablets in Healthy SubjectsKacey Anderson, Hao Zheng, Mona Kotecha, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 26, 2010
Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytesShringi Sharma, Ewa C S Ellis, Kenneth Dorko, et al.Pageof 4